[go: up one dir, main page]

RS20120367A3 - Methods and mixtures for treatment of viral hepatitis c - Google Patents

Methods and mixtures for treatment of viral hepatitis c

Info

Publication number
RS20120367A3
RS20120367A3 RS20120367A RSP36712A RS20120367A3 RS 20120367 A3 RS20120367 A3 RS 20120367A3 RS 20120367 A RS20120367 A RS 20120367A RS P36712 A RSP36712 A RS P36712A RS 20120367 A3 RS20120367 A3 RS 20120367A3
Authority
RS
Serbia
Prior art keywords
treatment
mixtures
methods
viral hepatitis
hepatitis
Prior art date
Application number
RS20120367A
Other languages
Serbian (sr)
Original Assignee
Indenix (Cayman) Limited
Universita Degli Studi Di Cagliari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indenix (Cayman) Limited, Universita Degli Studi Di Cagliari filed Critical Indenix (Cayman) Limited
Publication of RS20120367A2 publication Critical patent/RS20120367A2/en
Publication of RS20120367A3 publication Critical patent/RS20120367A3/en
Publication of RS53223B publication Critical patent/RS53223B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invention herewith described refers to the method and the compound for the treatment of hosts infected with hepatitis C virus, which includes the application of the described 1', 2' or 3'-modified nucleoside or its pharmaceutically acceptable salt or the pro-drug in an effective dose for the treatment of hepatitis C.
RS20120367A 2000-05-23 2001-05-23 METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C RS53223B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26058500P 2000-05-23 2000-05-23

Publications (3)

Publication Number Publication Date
RS20120367A2 RS20120367A2 (en) 2013-06-28
RS20120367A3 true RS20120367A3 (en) 2013-10-31
RS53223B RS53223B (en) 2014-08-29

Family

ID=48799830

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120367A RS53223B (en) 2000-05-23 2001-05-23 METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C

Country Status (1)

Country Link
RS (1) RS53223B (en)

Also Published As

Publication number Publication date
RS20120367A2 (en) 2013-06-28
RS53223B (en) 2014-08-29

Similar Documents

Publication Publication Date Title
EA200201279A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL HEPATITIS C
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
WO2003026589A3 (en) Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
EA200201263A1 (en) METHODS OF TREATING INFECTIONS, CAUSED BY THE HEPATITIS DELTA VIRUS, USING β-L-2'-DEOXYNUCLEOSIDES
TW200500373A (en) 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
EA200601591A1 (en) APPLICATION OF RIBONOUSALIC COMPOUNDS FOR TREATING FLAVIVIRUS AND PESTIVIRUS INFECTIONS
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
WO2001060315A3 (en) Method for the treatment or prevention of flavivirus infections using nucleoside analogues
EA200300819A1 (en) DERIVATIVES OF NUCLEOSIDES AS AN INHIBITORS RNA-DEPENDENT RNA VIRUS POLYMERASE
WO2007081517A8 (en) Anti-viral compounds
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
NO20051969L (en) Nucleoside derivatives for the treatment of hepatitis C virus infection.
WO2006101538A3 (en) Andrographolide derivatives to treat viral infections
DK1284720T3 (en) L-FMAU for the treatment of hepatitis delta virus infection
WO2003053332A3 (en) Composition and method for treating viral infection
RS20120367A3 (en) Methods and mixtures for treatment of viral hepatitis c
WO2002026249A3 (en) Methods for inhibition of viral infection
WO2003017943A3 (en) Therapeutic compositions and methods for treating viral infection
WO2003015714A3 (en) Compositions and therapeutic methods for viral infection
TW200745107A (en) Anti-viral compounds
GB0030203D0 (en) Assay